Maciek E. Orczyk
Business Adviser
Quantum
Australia
Biography
Dr. Maciek E. Orczyk is the Founder and Managing Director of Venture Gene LLC, an entrepreneurial management and venture capital advisory firm, and former Director of Strategic Investments at Intel Capital, one of the world's largest strategic venture capital investors in the area of advanced technology. Prior to Intel Capital, Maciek served in a variety of leadership roles within Intel Corp., including co-managing the Lithography Capital Equipment Development organization responsible for strategic technology roadmaps and business aspects of bringing new generations of patterning equipment to Intel, heading the Strategic Enabling Group in charge of identifying worldwide and bringing inside Intel novel manufacturing technologies required to maintain Intel's product release cycle (a.k.a. the Moore's Law), and chairing the Investment and Collaboration Management Review Committee responsible for external technology enabling programs and business deals across Intel's manufacturing technology area. Before joining Intel, Maciek was active in various areas of technology, including R&D management positions at Applied Materials Corp., technology development at an upstate New York startup developing nonlinear optical materials and systems for optical communications, data processing and storage, and academic research and teaching positions in the U.S. and Europe.
Research Interest
Dr. Maciek E. Orczyk is the Founder and Managing Director of Venture Gene LLC, an entrepreneurial management and venture capital advisory firm, and former Director of Strategic Investments at Intel Capital, one of the world's largest strategic venture capital investors in the area of advanced technology. Prior to Intel Capital, Maciek served in a variety of leadership roles within Intel Corp., including co-managing the Lithography Capital Equipment Development organization responsible for strategic technology roadmaps and business aspects of bringing new generations of patterning equipment to Intel, heading the Strategic Enabling Group in charge of identifying worldwide and bringing inside Intel novel manufacturing technologies required to maintain Intel's product release cycle (a.k.a. the Moore's Law), and chairing the Investment and Collaboration Management Review Committee responsible for external technology enabling programs and business deals across Intel's manufacturing technology area. Before joining Intel, Maciek was active in various areas of technology, including R&D management positions at Applied Materials Corp., technology development at an upstate New York startup developing nonlinear optical materials and systems for optical communications, data processing and storage, and academic research and teaching positions in the U.S. and Europe.
